UAB "Droplet Genomics" Finance - revenue, profit
Financial ratios
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 2,845,771 |
| 56,632 |
| -1,429,854 |
| -1,429,854 |
| -28,455 |
| 81.32 |
| -50.24 |
| 3,628,287 |
| 289,738 |
| 449,032 |
| 3,596,593 |
| 2024 |
|---|
| 3,689,650 |
| 62,483 |
| -835,007 |
| -835,007 |
| -14,141 |
| 79.41 |
| -22.63 |
| 4,141,797 |
| 637,290 |
| 494,690 |
| 4,419,344 |
| 2025 |
|---|
| 2,291,957 |
| 31,006 |
| -5,258,471 |
| -5,258,471 |
| -71,137 |
| 73.18 |
| -229.43 |
| 4,672,313 |
| 799,681 |
| 2,043,841 |
| 3,588,050 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 2,291,957 |
| 31,006 |
| -5,258,471 |
| -5,258,471 |
| -71,137 |
| 73.18 |
| -229.43 |
| 4,672,313 |
| 799,681 |
| 2,043,841 |
| 3,588,050 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
2,291,957 €-38 % *
Sales per employee (€)
31,006 €-50 % *
Profit before tax (€)
-5,258,471 €-530 % *
Net Profit (€)
-5,258,471 €-530 % *
Profit per employee (€)
-71,137 €-403 % *
Total profitability (%)
73.18 %-7.85 % *
Net profitability (%)
-229.43 %-913.83 % *
Equity (€)
4,672,313 €13 % *
Amounts Payable And Liabilities (€)
799,681 €25 % *
Non-current Assets (€)
2,043,841 €313 % *
CurrentAssets (€)
3,588,050 €-19 % *
